Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FXHKL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,592
Award facts
- Contract value 100% obligated
- $9,591.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,591.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on November 5, 2025, with completion targeted for November 6, 2025. This competitively awarded, non-set-aside contract represents a small-value pharmaceutical supply transaction executed through the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive product portfolio spanning brand-name medications, generics, vaccines, and specialized medical supplies.
This delivery order falls under AmerisourceBergen's larger DLA Troop Support Medical IDC (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products globally to support military healthcare programs. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive experience delivering diverse therapeutic medications including diabetes treatments and specialty pharmaceuticals, positions it as a key vendor within the DLA's Medical Supply Chain supporting military readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FXHKL?
SPE2DB26FXHKL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FXHKL worth?
The government has obligated $9,592 on SPE2DB26FXHKL.
Is contract SPE2DB26FXHKL an order under another contract?
Yes. SPE2DB26FXHKL is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHKL competed?
The extent of competition for SPE2DB26FXHKL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award